Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection

Send Inquiry

Request To Call Back

Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection

Name: Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection
Brand: New Delhi Speciality Pharma
Price: 2400 INR
Availability: InStock

Price 2400 INR/ Box

Get a Price/Quote

MOQ : 1 Box

Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection Specification

Brand Name
Erypeg 50

Indication
Chronic kidney disease-induced anemia

Salt Composition
Pegylated Recombinant Human Erythropoietin

Packaging Type
Box

Pacakaging (Quantity Per Box)
1 pre-filled syringe

Dosage Form
Injection

Origin of Medicine
India

Life Span
See pack for expiry

Drug Type
Biological

Ingredients
Pegylated Recombinant Human Erythropoietin

Physical Form
Solution Injection

Function
Stimulates red blood cell production

Recommended For
Anemia treatment

Dosage
As prescribed by physician

Dosage Guidelines
Follow doctors directions

Suitable For
Adults

Quantity
0.3ml

Storage Instructions
Store between 2C-8C

Prescription status
Prescription

Route of administration
Subcutaneous/IV

Color
Clear

Product Strength
50 mg

Sterility
Sterile

Product Code
Erypeg 50

Pack size
0.3 ml syringe

Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection Trade Information

Minimum Order Quantity
1 Box

Payment Terms
Cash in Advance (CID)

Supply Ability
10 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection

Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection is an acclaimed and polished therapeutic advancement, specially formulated for the monumental task of treating anemia associated with chronic kidney disease. Each sterile, clear 0.3 ml pre-filled syringe delivers a fresh and select dose of 50 mg Pegylated Recombinant Human Erythropoietin, ensuring resplendent efficacy in stimulating red blood cell production. Recommended for adult use under medical guidance, this solution exemplifies modern biotechnological achievement. With precise storage and packaging, Erypeg 50 upholds international standards, earning its reputation among India's leading exporters, suppliers, and traders.

Usage Guidelines and Suitable Application

Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection is administered via subcutaneous or intravenous routes and is exclusively recommended for adults suffering from anemia due to chronic kidney disease. Its usage is strictly by prescription, with dosage precisely determined by a physician based on individual patient needs. This powerful biological agent is intended for direct medical intervention and should never be self-administered. Its advanced formulation suits healthcare settings where professional oversight is available.

Certifications, Sample Policy, and Delivery Details

Erypeg 50 is produced adhering to exacting domestic and international quality certifications, assuring consistent sterility, potency, and safety. Goods transport is managed by reliable partners to swiftly reach both domestic markets and interested global buyers. Upon asking price confirmation, samples can be arranged for qualifying partners under our sample policy terms. Our streamlined delivery time ensures rapid, secure fulfillment, protecting the product's integrity from origin through to your supply chain partners.

FAQ's of Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection:

Q: How is Erypeg 50 Pegylated Recombinant Human Erythropoietin Solution Injection administered?

A: Erypeg 50 is administered either subcutaneously or intravenously by a healthcare professional, as prescribed by your physician.

Q: What is the primary benefit of using Erypeg 50 Injection?

A: The primary benefit of Erypeg 50 is the stimulation of red blood cell production, making it highly effective in treating anemia associated with chronic kidney disease.

Q: When should Erypeg 50 be used for anemia treatment?

A: Erypeg 50 is recommended when anemia is diagnosed in patients with chronic kidney disease and prescribed by a qualified physician.

Q: Where should Erypeg 50 be stored before use?

A: Erypeg 50 should be stored between 2C-8C in its original packaging to maintain product integrity and sterility.

Q: What is the process for obtaining Erypeg 50 for institutional use?

A: Institutions can procure Erypeg 50 through authorized exporters, suppliers, or traders, with arrangements made for sampling and confirmation of the asking price.